DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Frost FJ, Nazareth DS, Charman SC, Winstanley C, Walshaw MJ.
Ivacaftor Is associated with reduced lung infection by key cystic fibrosis pathogens. a cohort study Using National Registry Data.
Ann Am Thorac Soc 2019;
16 (11) 1375-1382
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.